GlassScriptPhysician profile
Ronald T Auer
NPI 1174848196
$7,645.96
in general payments reported to CMS, 2019-2025
12 companies · $2,394 in 2025
The $2,394 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $115 · 2021: $1,316 · 2022: $177 · 2023: $1,520 · 2024: $1,079 · 2025: $2,394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,952 · Food and Beverage: $2,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,952.47 |
| Food and Beverage | $2,039.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $4,097.81 | 2021-2025 | |
| Arthrex, INC. | $2,393.53 | 2019-2025 | Arthrex |
| Medacta USA, INC. | $499.29 | 2019-2025 | Gmk Sphere, Amistem |
| US Implant Solutions, LLC | $265.78 | 2019 | |
| Depuy Synthes Sales INC. | $137.09 | 2019-2021 | |
| Stryker Corporation | $89.59 | 2022-2023 | Blueprint Patient Specific Instrumentation |
| Medtronic, INC. | $69.97 | 2023-2024 | Intellis Adaptivestim, Aquamantys(Tm) |
| Merck Sharp & Dohme LLC | $28.22 | 2025 | Bridion |
| Vericel Corporation | $17.13 | 2019 | |
| Heron Therapeutics, INC. | $16.33 | 2023 | Zynrelef |
| Abbott Laboratories | $15.64 | 2019 | |
| Endo USA, INC. | $15.58 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Auer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.